The latest closing stock price for Compass Therapeutics as of November 20, 2024 is 1.37.
An investor who bought $1,000 worth of Compass Therapeutics stock at the IPO in 2021 would have $-614 today, roughly -1 times their original investment - a -27.19% compound annual growth rate over 3 years.
The all-time high Compass Therapeutics stock closing price was 5.48 on January 10, 2023.
The Compass Therapeutics 52-week high stock price is 2.34, which is 70.8% above the current share price.
The Compass Therapeutics 52-week low stock price is 0.77, which is 43.8% below the current share price.
The average Compass Therapeutics stock price for the last 52 weeks is 1.53.
An investor who bought $1,000 worth of Compass Therapeutics stock at the IPO in 2021 would have $-614 today, roughly -1 times their original investment - a -27.19% compound annual growth rate over 3 years.
The all-time high Compass Therapeutics stock closing price was 5.48 on January 10, 2023.
The Compass Therapeutics 52-week high stock price is 2.34, which is 70.8% above the current share price.
The Compass Therapeutics 52-week low stock price is 0.77, which is 43.8% below the current share price.
The average Compass Therapeutics stock price for the last 52 weeks is 1.53.